EBOS logo

EBO - EBOS Share Price

NZD30.29 -0.0  -0.0%

Last Trade - 11:06pm

Consumer Defensives
Large Cap
Market Cap £2.54bn
Enterprise Value £2.83bn
Revenue £4.97bn
Position in Universe 124th / 1913
Unlock EBO Revenue
Relative Strength (%)
1m +2.09%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.13%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
5,648 6,515 7,205 6,987 6,930 8,766 9,298 9,717 +9.2%
+16.1 +17.1 +11.4 +5.1 +5.1 +7.1 +13.8 +7.60
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 31 December 2020, EBOSGroup Ltd revenues increased 6% to A$4.65B. Net incomeincreased 14% to A$92.9M. Revenues reflect Healthcaresegment increase of 6% to A$4.41B, Animal Care segmentincrease of 16% to A$243.8M, Australia segment increase of6% to A$3.73B, New Zealand segment increase of 8% toA$927.1M. Net income benefited from Amortisation of finitelife intangibles decrease of 27% to A$6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for EBO
Graphical History


EBO Revenue Unlock EBO Revenue

Net Income

EBO Net Income Unlock EBO Revenue

Normalised EPS

EBO Normalised EPS Unlock EBO Revenue

PE Ratio Range

EBO PE Ratio Range Unlock EBO Revenue

Dividend Yield Range

EBO Dividend Yield Range Unlock EBO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
EBO EPS Forecasts Unlock EBO Revenue
Profile Summary

Ebos Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.

Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated September 11, 1922
Public Since June 16, 1986
No. of Shareholders: 9,388
No. of Employees: 3,300
Sector Consumer Defensives
Industry Food & Drug Retailing
Exchange New Zealand Stock Exchange
Shares in Issue 164,134,000
Free Float (0.0%)
Eligible for
EBO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for EBO
Upcoming Events for EBO
Wednesday 13th October, 2021 Estimate
EBOS Group Ltd Annual Shareholders Meeting
Frequently Asked Questions for EBOS
What is the EBOS share price?

As of 11:06pm, shares in EBOS are trading at NZD30.29, giving the company a market capitalisation of £2.54bn. This share price information is delayed by 15 minutes.

How has the EBOS share price performed this year?

Shares in EBOS are currently trading at NZD30.29 and the price has moved by 38.99% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the EBOS price has moved by 4.02% over the past year.

What are the analyst and broker recommendations for EBOS?

Of the analysts with advisory recommendations for EBOS, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for EBOS is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will EBOS next release its financial results?

EBOS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the EBOS dividend yield?

The EBOS dividend yield is 2.74% based on the trailing twelve month period.

Does EBOS pay a dividend?

Last year, EBOS paid a total dividend of 0.77, and it currently has a trailing dividend yield of 2.74%. Looking ahead, EBOS has not announced an ex-dividend date yet.

When does EBOS next pay dividends?

EBOS has yet to annouce their ex-dividend date. The historic dividend yield on EBOS shares is currently 2.74%.

How do I buy EBOS shares?

To buy shares in EBOS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of EBOS?

Shares in EBOS are currently trading at NZD30.29, giving the company a market capitalisation of £2.54bn.

Where are EBOS shares listed? Where are EBOS shares listed?

Here are the trading details for EBOS:

Country of listing: New Zealand
Exchange: NZC
Ticker Symbol: EBO
What kind of share is EBOS?

Based on an overall assessment of its quality, value and momentum, EBOS is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a EBOS share price forecast 2021?

Shares in EBOS are currently priced at NZD30.29. At that level they are trading at 1.93% discount to the analyst consensus target price of 0.00.

Analysts covering EBOS currently have a consensus Earnings Per Share (EPS) forecast of 1.158 for the next financial year.

How can I tell whether the EBOS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EBOS. Over the past six months, the relative strength of its shares against the market has been 11.2%. At the current price of NZD30.29, shares in EBOS are trading at 13.43% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the EBOS PE Ratio?

The EBOS PE ratio based on its reported earnings over the past 12 months is 25.96. The shares are currently trading at NZD30.29.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of EBOS?

EBOS's management team is headed by:

Elizabeth Coutts - NEC
David Lewis - GMG
Sean Duggan - CEX
Stuart McGregor - NED
Peter Williams - NED
Brett Barons - CEX
Simon Bunde - GMG
John Matthew Cullity - CEO
Janelle Cain - GCN
Andrea Bell - CIO
Stuart McLauchlan - NID
Nicholas Dowling - NID
Leonard Hansen - CFO
Jacinta McCarthy - GMG
Who are the major shareholders of EBOS?

Here are the top five shareholders of EBOS based on the size of their shareholding:

Sybos Holdings Pte. Ltd. Corporation
Percentage owned: 18.6% (30.5m shares)
Accident Compensation Corporation Insurance Company
Percentage owned: 3.67% (6.02m shares)
Harbour Asset Management Limited Investment Advisor
Percentage owned: 3.54% (5.82m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 2.55% (4.19m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 1.93% (3.17m shares)
Similar to EBO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.